Development and Validation of a Nomogram Predicting Intraoperative Adverse Events During Robot-assisted Partial Nephrectomy.

Journal: European urology focus
Published Date:

Abstract

BACKGROUND: Ability to predict the risk of intraoperative adverse events (IOAEs) for patients undergoing partial nephrectomy (PN) can be of great clinical significance.

Authors

  • Gopal Sharma
    Department of Urology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Milap Shah
  • Puneet Ahluwalia
    Max Institute of Cancer Care, Max Superspeciality Hospital, New Delhi, India.
  • Prokar Dasgupta
  • Benjamin J Challacombe
    Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Mahendra Bhandari
  • Rajesh Ahlawat
  • Sudhir Rawal
    Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
  • Nicolò M Buffi
    Humanitas Research Hospital, Milan, Italy.
  • Ananthakrishnan Sivaraman
    Apollo Hospitals, Chennai, India.
  • James R Porter
    Swedish Medical Centre, Seattle, WA, USA.
  • Craig Rogers
    Department of Urology, Henry Ford Health System, Detroit, MI, USA.
  • Alexandre Mottrie
    ORSI Academy Melle Belgium.
  • Ronney Abaza
    OhioHealth Robotic Urologic and Cancer Surgery, Dublin Methodist Hospital, Dublin, Ohio.
  • Khoon Ho Rha
    Yonsei University Health System, Seoul, South Korea.
  • Daniel Moon
    Peter MacCallum Hospital, University of Melbourne, Royal Melbourne Clinical School, Melbourne, Australia.
  • Thyavihally B Yuvaraja
    Kokilaben Dhirubhai Ambani Hospital, Mumbai, India.
  • Dipen J Parekh
    Miller School of Medicine, University of Miami, Miami, FL, USA. Electronic address: parekhd@miami.edu.
  • Umberto Capitanio
    Unit of Urology, Division of Experimental Oncology, Urological Research Institute (URI), IRCCS Ospedale San Raffaele, Milan, Italy.
  • Kris K Maes
    Centre for Robotic and Minimally Invasive Surgery, Hospital Da Luz, Luz Sáude, Portugal.
  • Francesco Porpiglia
    Division of Urology, Department of Oncology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy.
  • Levent Türkeri
    Acibadem University School of Medicine, Istanbul, Turkey.
  • Gagan Gautam
    Division of Urologic Oncology, Max Institute of Cancer Care, Saket, New Delhi, India.